Showing results (131-140 of 160) with videos related to
Sort By:
Pageof 16
Journal of Nutrition Education and Behavior|April 30, 2025
Time-Restricted Eating is a Feasible Dietary Strategy in the Treatment of Complicated Type 2 Diabetes: The RESET2 Pilot StudyAnne-Ditte Termannsen, Annemarie Varming, Gitte S Hansen, et al.Endocrinology, Diabetes & Metabolism|March 1, 2019
Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational studyFrederik Persson, Johan Bodegard, Jorma T Lahtela, et al.Journal of Clinical Medicine|June 5, 2019
Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System InhibitorsMie K Eickhoff, Claire C J Dekkers, Bart J Kramers, et al.The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical GuidanceMai Mohsen, Tae Won Yi, Labib Faruque, et al.Diabetologia|October 16, 2020
The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trialKristine Færch, Martin B Blond, Lea Bruhn, et al.Journal of Diabetes and Its Complications|October 29, 2024
Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS StudyElisabeth B Stougaard, Ninna Hahn Tougaard, Suvanjaa Sivalingam, et al.The New England Journal of Medicine|November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetesHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.Diabetes, Obesity & Metabolism|July 7, 2023
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetesViktor Rotbain Curovic, Morten B Houlind, Marjolein Y A M Kroonen, et al.Nature Reviews. Nephrology|April 3, 2024
Combination therapy for kidney disease in people with diabetes mellitusDaniël H van Raalte, Petter Bjornstad, David Z I Cherney, et al.Diabetes, Obesity & Metabolism|November 4, 2020
No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE-D trialKim K B Clemmensen, Martin B Blond, Hanan Amadid, et al.Pageof 16